(Nasdaq:TNDM) shares fell after hours today on second-quarter results that topped the consensus sales forecast.

Senseonics (NYSE:SENS) shares remained relatively unmoved today on second-quarter results that beat the consensus sales ...

The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said ...

Modular Medical (Nasdaq:MODD) announced today that it validated its insulin pump cartridge line for human-use production in ...

Swiss entrepreneur Willy Michel, who founded Ypsomed, controls TecMed. His son, Simon Michel, is CEO of Ypsomed. Included in ...

Sava Technologies announced today that it raised $19 million in a Series A financing round to support its wearable biosensor ...

Trividia Health announced today that it launched its new TRUEplus five-bevel insulin pen needle line in the UK.

What has changed in the last year as diabetes technology developers continue to innovate and advance their offerings?